Invitation to the launch of Smart Decisions: the 2024 G-FINDER Neglected Disease report

A flat line in overall global health R&D funding coupled with an increase in tropical diseases as the planet gets hotter means tough choices are on the agenda. Advances in malaria, TB, and snakebite treatments show the impact of well-targeted investments. Declines in funding for diseases like pneumonia and meningitis reflect a smart strategic shift following successful product launches. The overall HIV portfolio remains dynamic with funders pivoting strategies and leveraging innovations such as long-acting injectables and novel prophylactics.

But climate change is amplifying the disease burden and driving outbreaks in new parts of the world. Progress in tackling some diseases is at risk of backsliding despite significant unmet needs.

The challenge for funders and policy makers looking to have maximum impact is to understand the context, choose wisely, and find innovative approaches to lower the cost of R&D.

Join us for an online webinar as we launch the latest G-FINDER report on neglected diseases R&D. We will present the latest analysis of the funding landscape and explore how smart investment decisions can be made to deliver the greatest impact.

Thursday 30 January, 2025. 13:00-14:30 GMT

This will help you:

• Understand who is funding what
• Identify at-risk areas
• Assess potential for collaboration and partnership
• Evaluate your own priorities within a global context
• Strengthen your investment cases to deliver the greatest health and economic returns

The G-FINDER report is part of a series of insights and tools which Impact Global Health will bring you in 2025 to inform and support your decisions.